Behavioral dynamics of COVID-19: estimating under-reporting, multiple waves, and adherence fatigue across 92 nations

Hazhir Rahmandad; Tse Yang Lim; John Sterman

doi:10.1101/2020.06.24.20139451

Abstract

Effective responses to the COVID-19 pandemic require integrating behavioral factors such as risk-driven contact reduction, improved treatment, and adherence fatigue with asymptomatic transmission, disease acuity, and hospital capacity. We build one such model and estimate it for all 92 nations with reliable testing data. Cumulative cases and deaths through 22 December 2020 are estimated to be 7.03 and 1.44 times official reports, yielding an infection fatality rate (IFR) of 0.51% which has been declining over time. Absent adherence fatigue cumulative cases would have been 47% lower. Scenarios through June 2021 show that modest improvement in responsiveness could reduce cases and deaths ≈14%, more than the impact of vaccinating half of the population by that date. Variations in responsiveness to risk explain two orders of magnitude difference in per-capita deaths despite reproduction numbers fluctuating ∼ 1 across nations. A public online simulator facilitates scenario analysis over the coming months.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was used to conduct this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

- Updated with data until Dec 22, 2020 - Added 1 country to the estimates - Incorporated new risk-driven response functions - Incorporated impact of vaccination - Edited the manuscript extensively
↵¹ In the equations below we use short-hand to simplify mathematical notations. The full model documentation uses full variable names. Table S1 provides the mapping between the short-hand and the full names, as well as the sources and equations for the variables and parameters discussed below.
↵² https://blog.ons.gov.uk/2020/03/31/counting-deaths-involving-the-coronavirus-covid-19/
↵³ https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/previous-testing-in-us.html
↵⁴ See e.g. https://www.wcvb.com/article/massachusetts-coronavirus-reporting-delay-due-to-quest-lab-it-glitch/32288903#
↵⁵ It may be argued that there are weekly cycles in large-scale human behaviour that may drive some true weekly cyclicality in the true rates of infection and death, and as such it may be wrong to consider such cycles to be artefacts of the data- generation process. However, we find this unlikely for a few reasons. First, weekly cycles in human interactions, largely driven by the work and school week and weekend, will have been significantly attenuated by widespread adoption of social distancing measures around the world. Second and more importantly, variation in incubation period and time before development of symptoms means that any true cyclicality in the timing of initial infection will be further attenuated in the timing of symptom development. By the same logic, wide variability in the delay from symptom development to death means there should be minimal cyclicality, if any, in the timing of deaths, meaning any such cycles visible in the data are due to measurement and reporting lags.
↵⁶ https://docs.scipy.org/doc/scipy/reference/generated/scipy.interpolate.PchipInterpolator.html
↵⁷ Cleveland R.B., Cleveland W.S., McRae J.E., Terpenning I. (1990) STL: A seasonal-trend decomposition procedure based on Loess. J Off Stat 6: 3-73
↵⁸ https://www.statsmodels.org/stable/generated/statsmodels.tsa.seasonal.STL.html

Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

bioRxiv and medRxiv thank the following for their generous financial support:

The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

Community Reviews

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

Behavioral dynamics of COVID-19: estimating under-reporting, multiple waves, and adherence fatigue across 92 nations

Abstract

Competing Interest Statement

Funding Statement

Author Declarations

Footnotes

Data Availability

Subject Area

Citation Manager Formats

Behavioral dynamics of COVID-19: estimating under-reporting, multiple waves, and adherence fatigue across 92 nations

Abstract

Competing Interest Statement

Funding Statement

Author Declarations

Footnotes

Data Availability

Subject Area

Follow this preprint